{"content":"<li class=\"n-box-item date-title\" data-end=\"1486789199\" data-start=\"1486702800\" data-txt=\"Sunday, December 22, 2019\">Friday, February 10, 2017</li><li class=\"n-box-item sa-box-item\" data-id=\"3242697\" data-ts=\"1486769369\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYGN\" target=\"_blank\">MYGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242697-myriad-genetics-up-7_3-headed-to-smallcap-600\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myriad Genetics up 7.3%, headed to SmallCap 600</a></h4><ul>   <li>Myriad Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a>) is <font color='green'>up 7.3%</font> in after-hours trade on news that it's <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/483952_mygn6.pdf?force_download=true\" target=\"_blank\">headed into the S&amp;P SmallCap 600</a>.</li>    <li>It will replace Inteliquent (NASDAQ:<a href='https://seekingalpha.com/symbol/IQNT' title='Inteliquent, Inc.'>IQNT</a>) in that index, as private-equity firm GTCR's <a href=\"https://seekingalpha.com/news/3220087-inteliquent-agrees-23-share-buyout-33_7-percent\" target=\"_blank\">$23/share buyout</a> of the company <a href=\"https://seekingalpha.com/pr/16739394-gtcr-completes-acquisition-inteliquent\" target=\"_blank\">wrapped up today</a>.</li>    <li>Personalized-medicine firm Myriad will be added to the Biotechnology sub-industry index after the close Tuesday.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242697\" data-linked=\"Myriad Genetics up 7.3%, headed to SmallCap 600\" data-tweet=\"$MYGN $MYGN $IQNT - Myriad Genetics up 7.3%, headed to SmallCap 600 https://seekingalpha.com/news/3242697-myriad-genetics-up-7_3-headed-to-smallcap-600?source=tweet\" data-url=\"https://seekingalpha.com/news/3242697-myriad-genetics-up-7_3-headed-to-smallcap-600\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242696\" data-ts=\"1486769281\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRA\" target=\"_blank\">VRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242696-vera-bradley-cfo-sierks-to-depart\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vera Bradley CFO Sierks to depart</a></h4><ul>     <li>Vera Bradley (NASDAQ:<a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a>) <font color='red'>-2.8%</font> AH after disclosing that CFO Kevin Sierks <a href=\"https://seekingalpha.com/filing/3399533\" target=\"_blank\">will leave the company</a>, effective March 31.</li>     <li>Sierks became VRA's fulltime CFO in 2014 after serving a year as interim CFO; before joining VRA in 2011, he was VP and controller at Biomet and director of accounting at Boston Scientific.</li>     <li>VP of Financial Planning and Analysis John Enwright will become interim CFO; he joined VRA in 2014 after holding various financial positions of increasing  responsibility at Tiffany for 15 years.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242696\" data-linked=\"Vera Bradley CFO Sierks to depart\" data-tweet=\"$VRA - Vera Bradley CFO Sierks to depart https://seekingalpha.com/news/3242696-vera-bradley-cfo-sierks-to-depart?source=tweet\" data-url=\"https://seekingalpha.com/news/3242696-vera-bradley-cfo-sierks-to-depart\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242693\" data-ts=\"1486768342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WCIC\" target=\"_blank\">WCIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242693-lennar-closes-643m-deal-for-wci-communities\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lennar closes $643M deal for WCI Communities</a></h4><ul>   <li>Lennar (<a href='https://seekingalpha.com/symbol/LEN' title='Lennar Corporation'>LEN</a> <font color='green'>+3.6%</font>) has <a href=\"https://seekingalpha.com/filing/3400145\" target=\"_blank\">closed on its acquisition</a> of WCI Communities (NYSE:<a href='https://seekingalpha.com/symbol/WCIC' title='WCI Communities, Inc.'>WCIC</a>) at an equity value of $643M.</li>    <li>It's paying all cash consideration, $23.50/share for WCI common stock held before the merger became effective. The two made the deal at an enterprise value for WCI of $809M.</li>    <li>As part of the deal, Lennar becomes a co-issuer on WCI's 6.875% senior notes due 2021, of which $250M are outstanding.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242693\" data-linked=\"Lennar closes $643M deal for WCI Communities\" data-tweet=\"$WCIC $WCIC $LEN - Lennar closes $643M deal for WCI Communities https://seekingalpha.com/news/3242693-lennar-closes-643m-deal-for-wci-communities?source=tweet\" data-url=\"https://seekingalpha.com/news/3242693-lennar-closes-643m-deal-for-wci-communities\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:12 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242688\" data-ts=\"1486766227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242688-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers, as of 5.25 p.m.:</b> <a href='https://seekingalpha.com/symbol/MYGN' title='Myriad Genetics, Inc.'>MYGN</a> <font color='green'>+6.9%</font>. <a href='https://seekingalpha.com/symbol/GLAD' title='Gladstone Capital'>GLAD</a> <font color='green'>+3.3%</font>. <a href='https://seekingalpha.com/symbol/OSUR' title='OraSure Technologies, Inc.'>OSUR</a> <font color='green'>+1.7%</font>. <a href='https://seekingalpha.com/symbol/PDS' title='Precision Drilling Corporation'>PDS</a> <font color='green'>+1.6%</font>. <a href='https://seekingalpha.com/symbol/NCR' title='NCR Corporation'>NCR</a> <font color='green'>+1.5%</font>.</li><li><b>Top losers, as of 5.25p.m.:</b> <a href='https://seekingalpha.com/symbol/VRA' title='Vera Bradley'>VRA</a> <font color='red'>-2.9%</font>. <a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='red'>-2.6%</font>. SHLD <font color='red'>-2.6%</font>. <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='red'>-2.4%</font>. <a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='red'>-1.6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242688\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$MYGN $GLAD $OSUR - After Hours Gainers / Losers https://seekingalpha.com/news/3242688-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3242688-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242681\" data-ts=\"1486764625\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242681-twilio-unlocks-final-pool-of-ipo-restrained-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio unlocks final pool of IPO-restrained shares</a></h4><ul><li>Approximately 31M of 36M Twilio shares had remained restricted among insiders as of January 19 in a follow-on associated lockup due to a corporate trading blackout related to earnings timing. This period followed initial IPO&nbsp;lockup expiry (31M shares) in December 2016.</li><li>As of today's market open, the 31M shares previously subject to blackout regulation have gone unlocked, making all 67M originally repressed shares available to be sold.</li><li>Twilio (NYSE:<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a>) today $31.96,&nbsp;<font color='red'>-2.59%</font>&nbsp;(volume 9.47M over 4.53M average).</li><li>Earlier this week (February 7, 2017): <a href=\"https://seekingalpha.com/news/3241349-twilio-plus-2_55-percent-q4-2016-results-revenue-forecasts-expectations\" target=\"_blank\">Twilio +2.55%; Q4 2016 results, revenue forecasts over expectations</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242681\" data-linked=\"Twilio unlocks final pool of IPO-restrained shares\" data-tweet=\"$TWLO - Twilio unlocks final pool of IPO-restrained shares https://seekingalpha.com/news/3242681-twilio-unlocks-final-pool-of-ipo-restrained-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3242681-twilio-unlocks-final-pool-of-ipo-restrained-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>64&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242671\" data-ts=\"1486763541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242671-weekly-etf-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/URA' title='Global X Uranium ETF'>URA</a> <font color='green'>+8.9%</font>. <a href='https://seekingalpha.com/symbol/GDXJ' title='VanEck Vectors Junior Gold Miners ETF'>GDXJ</a> <font color='green'>+6.5%</font>. <a href='https://seekingalpha.com/symbol/GAZ' title='iPath DJ-UBS Natural Gas Total Return Sub-Index ETN'>GAZ</a> <font color='green'>+4.1%</font>. <a href='https://seekingalpha.com/symbol/FXI' title='iShares China Large-Cap ETF'>FXI</a> <font color='green'>+3.8%</font>. <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a> <font color='green'>+3.2%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/FXE' title='CurrencyShares Euro Trust ETF'>FXE</a> <font color='red'>-1.4%</font>. <a href='https://seekingalpha.com/symbol/EWY' title='iShares MSCI South Korea Capped ETF'>EWY</a> <font color='red'>-1.3%</font>. <a href='https://seekingalpha.com/symbol/REMX' title='VanEck Vectors Rare Earth/Strategic Metals ETF'>REMX</a> <font color='red'>-1.3%</font>. <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a> <font color='red'>-1.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242671\" data-linked=\"Weekly ETF Gainers / Losers\" data-tweet=\"$URA $GDXJ $GAZ-OLD - Weekly ETF Gainers / Losers https://seekingalpha.com/news/3242671-weekly-etf-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3242671-weekly-etf-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242661\" data-ts=\"1486761808\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MX\" target=\"_blank\">MX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242661-magnachip-semiconductorminus-9_15-needham-company-considers-oversold-reiterates-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MagnaChip Semiconductor -9.15%; Needham &amp; Company considers oversold, reiterates Buy</a></h4><ul><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Magnachip+%28MX%29+Looks+Oversold+-+Needham+%26+Company/12526986.html\" target=\"_blank\">Analyst Rajvindra Gill</a>&nbsp;spotlights MagnaChip Semiconductor's (NYSE:<a href='https://seekingalpha.com/symbol/MX' title='MagnaChip Semiconductor Corporation'>MX</a>) <a href=\"https://seekingalpha.com/pr/16738917-magnachip-reports-fourth-quarter-2016-financial-results\" target=\"_blank\">Q4 2016 and future outlook</a> as encouraging amid an ongoing turnaround narrative, while attributing today's sell-off to <a href=\"https://seekingalpha.com/article/4044895-magnachip-semiconductors-mx-ceo-yj-kim-q4-2016-results-earnings-call-transcript\" target=\"_blank\">management commentary</a> indicating lower AMOLED revenue for H1 2017, prior to an expected ramp in H2 2017. Remains, however, confident in the company's AMOLED design win pipeline as well as positive on MagnaChip Semiconductor's continued prioritization of improvement in gross margin, cash flow and profitability.</li><li>Reissues $10 price target (current price $7.45).</li></ul><div class=\"tiny-share-widget\" data-id=\"3242661\" data-linked=\"MagnaChip Semiconductor -9.15%; Needham &amp; Company considers oversold, reiterates Buy\" data-tweet=\"$MX - MagnaChip Semiconductor -9.15%; Needham &amp; Company considers oversold, reiterates Buy https://seekingalpha.com/news/3242661-magnachip-semiconductorminus-9_15-needham-company-considers-oversold-reiterates-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3242661-magnachip-semiconductorminus-9_15-needham-company-considers-oversold-reiterates-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:23 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242656\" data-ts=\"1486761071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KNL\" target=\"_blank\">KNL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242656-knoll-eps-in-line-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Knoll EPS in-line, misses on revenue</a></h4><ul><li>Knoll (NYSE:<a href='https://seekingalpha.com/symbol/KNL' title='Knoll, Inc.'>KNL</a>): Q4 EPS of $0.44 in-line.</li><li>Revenue of $292.9M (-4.2% Y/Y) <font color='red'>misses by $20.65M</font>.</li><li>Shares <font color='green'>+2.73%</font>.</li><li><a href='http://phx.corporate-ir.net/phoenix.zhtml?c=66169&p=irol-newsArticle&ID=2245246'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242656\" data-linked=\"Knoll EPS in-line, misses on revenue\" data-tweet=\"$KNL - Knoll EPS in-line, misses on revenue https://seekingalpha.com/news/3242656-knoll-eps-in-line-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3242656-knoll-eps-in-line-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242650\" data-ts=\"1486759011\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBR\" target=\"_blank\">PBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242650-brazil-court-suspends-5_2b-sale-of-petrobras-gas-pipeline-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brazil court suspends $5.2B sale of Petrobras gas pipeline unit</a></h4><ul>     <li>A Brazilian federal court has <a href=\"https://www.bloomberg.com/news/articles/2017-02-10/petrobras-5-2-billion-deal-with-brookfield-halted-by-court\" target=\"_blank\">suspended</a> Petrobras' (<a href='https://seekingalpha.com/symbol/PBR' title='Petrobras - Petroleo Brasileiro S.A.'>PBR</a> <font color='green'>+2.7%</font>) $5.2B sale of the Nova Transportadora do Sudesteon natural gas pipeline unit to a group of investors led by Brookfield Asset Management (<a href='https://seekingalpha.com/symbol/BAM' title='Brookfield Asset Management Inc.'>BAM</a> <font color='red'>-0.4%</font>).</li>     <li>The court granted the injunction on grounds that the sale was not sufficiently publicized to foster competition.</li>     <li>Nova Transportadora supplies gas to Brazil&rsquo;s most populated and industrialized states of Sao Paulo, Rio de Janeiro and Minas Gerais.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242650\" data-linked=\"Brazil court suspends $5.2B sale of Petrobras gas pipeline unit\" data-tweet=\"$PBR $PBR $BAM - Brazil court suspends $5.2B sale of Petrobras gas pipeline unit https://seekingalpha.com/news/3242650-brazil-court-suspends-5_2b-sale-of-petrobras-gas-pipeline-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3242650-brazil-court-suspends-5_2b-sale-of-petrobras-gas-pipeline-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242647\" data-ts=\"1486757988\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SKX\" target=\"_blank\">SKX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242647-skechers-soars-20-on-strong-sales-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Skechers soars 20% on strong sales numbers</a></h4><ul><li>The company <a href=\"https://seekingalpha.com/news/3242342-skechers-higher-revenue-growth-impresses\" target=\"_blank\">topped revenue estimates </a>in Q4, and Q1 revenue guidance was also stronger-than-expected ($1.05B-$1.075B vs. Street at $1.04B).</li><li>But what about profits, <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/02/10/skechers-jumps-20-on-mixed-q4-earnings-guidance/?mod=BOL_hp_blog_stw\" target=\"_blank\">asks Wedbush's Christopher Svezia</a>, reiterating his Neutral rating and $25 price target (vs. current $27.87).</li><li>The Q4 bottom line of $0.04 missed estimates by a nickel, and Q1 EPS guidance of $0.50-$0.55 is shy of the Street at $0.66.</li><li>For now, sales growth isn't translating into profits and the \"inflection continues to move further out, increasing risk should growth not materialize,\" he says.</li><li><a href=\"https://seekingalpha.com/symbol/SKX/earnings\" target=\"_blank\">Skechers earnings center</a>, including conference call transcript</li><li><a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a><font color='green'> +19.6%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3242647\" data-linked=\"Skechers soars 20% on strong sales numbers\" data-tweet=\"$SKX - Skechers soars 20% on strong sales numbers https://seekingalpha.com/news/3242647-skechers-soars-20-on-strong-sales-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/3242647-skechers-soars-20-on-strong-sales-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242642\" data-ts=\"1486756828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242642-technology-top-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 3:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SWIR' title='Sierra Wireless, Inc.'>SWIR</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/CPSI' title='Computer Programs and Systems, Inc.'>CPSI</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ECOM' title='ChannelAdvisor Corp'>ECOM</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/IPAS' title='IPASS INC'>IPAS</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/UBNT' title='Ubiquiti Networks, Inc.'>UBNT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/FNCX' title='Function&#40;x&#41; Inc.'>OTC:FNCX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a> <font color='red'>-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242642\" data-linked=\"Technology - Top Gainers / Losers as of 3:00 pm\" data-tweet=\"$SWIR $INFN $CTRL - Technology - Top Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3242642-technology-top-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3242642-technology-top-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242630\" data-ts=\"1486754115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242630-freeport-says-no-new-indonesia-export-permit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport says it has no new Indonesia export permit</a></h4><ul>     <li>Freeport McMoRan (<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+2.9%</font>) says it has <a href=\"http://www.reuters.com/article/us-indonesia-freeport-exports-idUSKBN15P23V\" target=\"_blank\">not yet reached an agreement</a> with Indonesia's government on a new permit for its Grasberg mine, and copper concentrate exports remain restricted.</li>     <li>The government <a href=\"https://seekingalpha.com/news/3242508-freeport-plus-4-percent-indonesia-reportedly-issues-new-mining-permit\" target=\"_blank\">reportedly had issued</a> a new mining permit to FCX after halting shipments of copper concentrate exports on Jan. 12.</li><li>Nevertheless, FCX is sharply higher along with the price of copper after BHP&nbsp;Billiton <a href=\"https://seekingalpha.com/news/3242614-bhps-escondida-copper-mine-declares-force-majeure\" target=\"_blank\">declared force majeure</a> on shipments from its Escondida mine amid a workers strike.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242630\" data-linked=\"Freeport says it has no new Indonesia export permit\" data-tweet=\"$FCX - Freeport says it has no new Indonesia export permit https://seekingalpha.com/news/3242630-freeport-says-no-new-indonesia-export-permit?source=tweet\" data-url=\"https://seekingalpha.com/news/3242630-freeport-says-no-new-indonesia-export-permit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242629\" data-ts=\"1486754083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/P\" target=\"_blank\">P</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242629-pandoraplus-2_5-analysts-positive-despite-profit-challenges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pandora +2.5% with analysts positive despite profit challenges</a></h4><ul>   <li>Following postmarket declines after an <a href=\"https://seekingalpha.com/news/3242363-pandora-media-minus-2_8-percent-earnings-report-features-light-q1-guidance\" target=\"_blank\">earnings report</a> that featured dim forward guidance, Pandora Media (NYSE:<a href='https://seekingalpha.com/symbol/P' title='Pandora Media'>P</a>) is <font color='green'>up 2.5%</font> with analysts largely confident about prospects.</li>    <li>B. Riley reiterated its Buy rating and holds a $17 price target, implying 31% upside. And RBC Capital Markets has boosted its price target to $16.</li>    <li>Wedbush stuck with its Outperform rating and $15 price target even while acknowledging it's unlikely the company will become profitable this year.</li>    <li>&ldquo;Pandora could surpass our 2017 revenue estimates, but we believe <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/17/02/9025044/pandora-investors-expect-losses-through-most-of-2017\" target=\"_blank\">overall profitability in 2017 is less likely</a>,&rdquo; says Michael Pachter.</li>    <li>But: &ldquo;We believe that Pandora can convert at least 1M Pandora Plus subscribers to on-demand and can attract 1&ndash;2M net new U.S. on-demand subscribers in 2017, while up-selling ad-supported customers to its Pandora Plus service.\"</li>    <li>Cowen &amp; Co., meanwhile, lowered its price target on shares, to $9 -- 30% downside from current price.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242629\" data-linked=\"Pandora +2.5% with analysts positive despite profit challenges\" data-tweet=\"$P - Pandora +2.5% with analysts positive despite profit challenges https://seekingalpha.com/news/3242629-pandoraplus-2_5-analysts-positive-despite-profit-challenges?source=tweet\" data-url=\"https://seekingalpha.com/news/3242629-pandoraplus-2_5-analysts-positive-despite-profit-challenges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242626\" data-ts=\"1486753228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242626-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/WRN' title='Western Copper and Gold Corporation'>WRN</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/GLF' title='GulfMark Offshore, Inc.'>GLF</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/TGA' title='Transglobe Energy Corp'>TGA</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies'>FET</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242626\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$WRN $GLF $SDRL - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3242626-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3242626-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242701\" data-ts=\"1486753086\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VALE\" target=\"_blank\">VALE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242701-iron-ore-prices-jump-to-29-month-high-on-surging-china-imports\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Iron ore prices jump to 29-month high on surging China imports</a></h4><ul><li><a href=\"http://www.marketwatch.com/story/iron-ore-prices-hit-2-year-high-as-china-imports-jump-2017-02-10\" target=\"_blank\">Iron ore prices rose</a> today to the highest in nearly two and a half years  after data from China showed surging iron ore imports.</li><li>Platts&rsquo; IODEX prices for 62% iron ore fines delivered to China surged 3% to $86.60/metric ton, the highest level since September 2014, after the Chinese government said January iron ore imports rose to 92M metric tons, up 11.9% Y/Y and 3.4% from the previous month.</li><li>&ldquo;The continued strong iron ore import totals represent to us continued  strength in China&rsquo;s steel sector, which we expect to continue&rdquo; to H2 2017, Barclays says.</li><li>The world's top three iron ore producers are higher: <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+5%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='green'>+5.2%</font>, <a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='green'>+2.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242701\" data-linked=\"Iron ore prices jump to 29-month high on surging China imports\" data-tweet=\"$VALE $VALE $RIO - Iron ore prices jump to 29-month high on surging China imports https://seekingalpha.com/news/3242701-iron-ore-prices-jump-to-29-month-high-on-surging-china-imports?source=tweet\" data-url=\"https://seekingalpha.com/news/3242701-iron-ore-prices-jump-to-29-month-high-on-surging-china-imports\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242625\" data-ts=\"1486752218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESIO\" target=\"_blank\">ESIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242625-electro-scientific-industries-higher-6_3-on-corporate-restructuring-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Electro Scientific Industries higher 6.3% on corporate restructuring plans</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ESIO' title='Electro Scientific Industries, Inc.'>ESIO</a> <font color='green'>+6.3%</font> expects to reduce its cost structure by $10 to $12M on an annualized basis and lower its non-GAAP EBITDA breakeven point to approx. $35M of quarterly revenue once the corporate restructuring actions are fully implemented.</li><li>The company expects pre-tax charges of $6.5 to $8.5M, of which aprox.$5M is expected to be recorded in the 4Q17.</li><li>The corporate actions are expected to be largely completed by the end of June 2017.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242625\" data-linked=\"Electro Scientific Industries higher 6.3% on corporate restructuring plans\" data-tweet=\"$ESIO - Electro Scientific Industries higher 6.3% on corporate restructuring plans https://seekingalpha.com/news/3242625-electro-scientific-industries-higher-6_3-on-corporate-restructuring-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3242625-electro-scientific-industries-higher-6_3-on-corporate-restructuring-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242618\" data-ts=\"1486750890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EARN\" target=\"_blank\">EARN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242618-ellington-residentialplus-5_5-after-strong-q4-performance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ellington Residential +5.5% after strong Q4 performance</a></h4><ul><li>Q4 core earnings of $4.9M or $0.54 per share vs. $2.9M and $0.32 in Q3. Dividend is $0.40. Excluding catch-up premium amortization adjustment, core EPS of $0.47 vs. $0.48 in Q3.</li><li>End-of-Q4 book value per share of $15.52 slips from $15.70 three months earlier. After today's big gain, shares are trading at a 10% discount to book.</li><li>Economic return for quarter $0.22, or 5.6% annualized - a seemingly modest number, but compared to sizable negative returns at other mREITs, it may qualify as a blowout.</li><li>Net interest margin of 1.89% up from 1.30% in Q3; excluding catch-up premium amortization adjustment of 1.69% down eight basis points from Q3.</li><li><a href=\"http://ir.earnreit.com/phoenix.zhtml?c=251770&amp;p=irol-presentations\" target=\"_blank\">Earnings call slides</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3242426-ellington-residential-mortgage-reit-beats-0_02\" target=\"_blank\">Ellington Residential Mortgage REIT beats by $0.02</a> (Feb. 10)</li><li><a href='https://seekingalpha.com/symbol/EARN' title='Ellington Residential Mortgage REIT'>EARN</a>&nbsp;<font color='green'>+5.5%</font>&nbsp;to $13.92.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242618\" data-linked=\"Ellington Residential +5.5% after strong Q4 performance\" data-tweet=\"$EARN - Ellington Residential +5.5% after strong Q4 performance https://seekingalpha.com/news/3242618-ellington-residentialplus-5_5-after-strong-q4-performance?source=tweet\" data-url=\"https://seekingalpha.com/news/3242618-ellington-residentialplus-5_5-after-strong-q4-performance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242616\" data-ts=\"1486750242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242616-financials-top-5-gainers-losers-of-1-10-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:10 PM</a></h4><ul><li><b>Gainers:</b> CBG <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/BSBR' title='Banco Santander &#40;Brasil&#41; S.A.'>BSBR</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/EARN' title='Ellington Residential Mortgage REIT'>EARN</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MBTF' title='M B T Financial Corp'>MBTF</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/TBBK' title='The Bancorp, Inc.'>TBBK</a> <font color='red'>-5%</font>. FXCM <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242616\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:10 PM\" data-tweet=\"$CBRE $BSBR $EARN - Financials - Top 5 Gainers / Losers as of 1:10 PM https://seekingalpha.com/news/3242616-financials-top-5-gainers-losers-of-1-10-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3242616-financials-top-5-gainers-losers-of-1-10-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242699\" data-ts=\"1486750163\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIO\" target=\"_blank\">RIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242699-rio-tinto-recruits-three-energy-executives-to-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rio Tinto recruits three energy executives to board</a></h4><ul>     <li>Rio Tinto (<a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='green'>+5.2%</font>) says it <a href=\"http://www.reuters.com/article/shell-moves-cfo-idUSL5N1FV3XB\" target=\"_blank\">appointed</a> three former senior managers from the energy industry to its board as non-executive directors, including departing Royal Dutch Shell CFO Simon Henry.</li>     <li>Henry, who is stepping down as CFO at Shell after seven years on March  9, will join Rio on July 1, while former Centrica CEO Sam Laidlaw and  ex-Sasol CEO David Constable will begin their new posts  immediately.</li><li>The appointments, which will add significant energy industry expertise to Rio's board, are noteworthy in light of previous comments by CEO Jean-Sebastien Jacques that he was not interested in expanding Rio into the oil and gas industry.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242699\" data-linked=\"Rio Tinto recruits three energy executives to board\" data-tweet=\"$RIO - Rio Tinto recruits three energy executives to board https://seekingalpha.com/news/3242699-rio-tinto-recruits-three-energy-executives-to-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3242699-rio-tinto-recruits-three-energy-executives-to-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242614\" data-ts=\"1486749488\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHP\" target=\"_blank\">BHP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242614-bhps-escondida-copper-mine-declares-force-majeure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BHP&#39;s Escondida copper mine declares force majeure</a></h4><ul>     <li>BHP Billiton (<a href='https://seekingalpha.com/symbol/BHP' title='BHP Billiton Limited'>BHP</a> <font color='green'>+2.1%</font>) <a href=\"http://www.reuters.com/article/chile-copper-escondida-idUSL1N1FV0U5\" target=\"_blank\">declares force majeure</a> on shipments from  its Escondida mine in Chile, as a two-day-old workers' strike brings production to a standstill.</li>     <li>LME copper prices shot up 4.5% to $6,083/metric ton, the highest since June 2015, and mining stocks are rallying: <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+3.9%</font>, <a href='https://seekingalpha.com/symbol/RIO' title='Rio Tinto plc'>RIO</a> <font color='green'>+4.9%</font>, <a href='https://seekingalpha.com/symbol/VALE' title='Vale S.A.'>VALE</a> <font color='green'>+4.6%</font>.</li>     <li>The miners union says it is <a href=\"https://www.bloomberg.com/news/articles/2017-02-09/bhp-union-boss-readies-for-months-long-strike-amid-wage-deadlock\" target=\"_blank\">preparing for a long strike</a>, as it builds a workers&rsquo; camp outside the mine that&rsquo;s designed to last at least two months.</li>     <li>ETFs: <a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/CUPM' title='iPath Pure Beta Copper ETN'>CUPM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3242614\" data-linked=\"BHP&#39;s Escondida copper mine declares force majeure\" data-tweet=\"$BHP $BHP $FCX - BHP&#39;s Escondida copper mine declares force majeure https://seekingalpha.com/news/3242614-bhps-escondida-copper-mine-declares-force-majeure?source=tweet\" data-url=\"https://seekingalpha.com/news/3242614-bhps-escondida-copper-mine-declares-force-majeure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242610\" data-ts=\"1486748689\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242610-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> SHLD <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/SWIR' title='Sierra Wireless, Inc.'>SWIR</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/QUOT' title='Quotient Technology Inc.'>QUOT</a> <font color='green'>+18%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ECOM' title='ChannelAdvisor Corp'>ECOM</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/TCON' title='Tracon Pharmaceuticals'>TCON</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/IPAS' title='IPASS INC'>IPAS</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/SMSI' title='Smith Micro Software, Inc.'>SMSI</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/APDN' title='Applied DNA Sciences, Inc.'>APDN</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/UBNT' title='Ubiquiti Networks, Inc.'>UBNT</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/MX' title='MagnaChip Semiconductor Corporation'>MX</a> <font color='red'>-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242610\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SHLDQ $SWIR $INFN - Midday Gainers / Losers https://seekingalpha.com/news/3242610-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3242610-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242606\" data-ts=\"1486747843\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NE\" target=\"_blank\">NE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242606-noble-corpplus-12-on-smaller-expected-q4-loss-lifting-drillers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Noble Corp. +12% on smaller than expected Q4 loss, lifting drillers</a></h4><ul><li>Noble Corp. (<a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='green'>+12.7%</font>) surges after reporting a narrower than expected <a href=\"https://seekingalpha.com/news/3242372-noble-corp-beats-0_07-beats-revenue\" target=\"_blank\">Q4 loss</a> and stronger than expected revenues of $410M, even though sales came in 52% below year-ago levels and analysts remain <a href=\"http://blogs.barrons.com/stockstowatchtoday/2017/02/10/noble-corp-jumps-on-upbeat-q4-earnings/\" target=\"_blank\">generally neutral</a> on the stock.</li><li>NE says its $1B-plus revenue base, along with further  reductions in contract drilling costs and capital spending, should  result in another year of positive free cash flow.</li><li>Stephens reiterates an Equal Weight rating and $7 price target on the stock, saying NE has proven its ability to successfully manage its cost structure, execute operationally and generate cash flow (~$105M in Q4) despite difficult market conditions.</li><li>Raymond James reiterates its Market Perform rating, as NE&rsquo;s commitment to cost rationalization largely drove the better than expected Q4 results, with contract drilling expenses of $177M coming in below the middle of NE&rsquo;s $190M-$205M guidance range.</li><li>Offshore drillers are broadly higher: <a href='https://seekingalpha.com/symbol/RIG' title='Transocean Ltd.'>RIG</a> <font color='green'>+2.1%</font>, <a href='https://seekingalpha.com/symbol/ATW' title='Atwood Oceanics Inc.'>ATW</a> <font color='green'>+3%</font>, <a href='https://seekingalpha.com/symbol/RDC' title='Rowan Companies plc'>RDC</a> <font color='green'>+3.1%</font>, <a href='https://seekingalpha.com/symbol/ESV' title='Ensco PLC'>ESV</a> <font color='green'>+6.9%</font>, <a href='https://seekingalpha.com/symbol/DO' title='Diamond Offshore Drilling Inc.'>DO</a> <font color='green'>+4.6%</font>, <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='green'>+13.1%</font>, <a href='https://seekingalpha.com/symbol/PACD' title='Pacific Drilling SA'>PACD</a> <font color='green'>+5.2%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242606\" data-linked=\"Noble Corp. +12% on smaller than expected Q4 loss, lifting drillers\" data-tweet=\"$NE $NE $RIG - Noble Corp. +12% on smaller than expected Q4 loss, lifting drillers https://seekingalpha.com/news/3242606-noble-corpplus-12-on-smaller-expected-q4-loss-lifting-drillers?source=tweet\" data-url=\"https://seekingalpha.com/news/3242606-noble-corpplus-12-on-smaller-expected-q4-loss-lifting-drillers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242592\" data-ts=\"1486746307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBLU\" target=\"_blank\">JBLU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242592-jetblue-airways-january-traffic-up-8_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JetBlue Airways January traffic up 8.6%</a></h4><ul> <li>JetBlue (<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a> <font color='red'>-1.3%</font>) reports revenue passenger miles rose 8.6% in January to 3.863B.</li><li>Capacity increased 7.7% Y/Y to 4.637B available seat miles.</li><li>January load factor +70 bps to 83.3%.</li><li>Preliminary revenue per available seat mile declined ~8.5% during the month.</li><li><a href=\"https://seekingalpha.com/pr/16739239-jetblue-airways-reports-january-traffic\" target=\"_blank\">Press release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242592\" data-linked=\"JetBlue Airways January traffic up 8.6%\" data-tweet=\"$JBLU - JetBlue Airways January traffic up 8.6% https://seekingalpha.com/news/3242592-jetblue-airways-january-traffic-up-8_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3242592-jetblue-airways-january-traffic-up-8_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242597\" data-ts=\"1486746145\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242597-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/COLM' title='Columbia Sportswear Company'>COLM</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CMT' title='Core Molding Technologies, Inc.'>CMT</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242597\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SKX $COLM $VUZI - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3242597-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3242597-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242594\" data-ts=\"1486745798\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBRE\" target=\"_blank\">CBRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242594-cbre-groupplus-9-after-big-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CBRE Group +9% after big earnings beat</a></h4><ul><li>Q4 adjusted net income of $314.7M up 16% Y/Y; adjusted EPS of $0.93 up 15%. Full-year adjusted EPS up 12% to $2.30.</li><li>Stripping out forex impact, adjusted EPS rose 19% Y/Y in Q4.</li><li>Q4 adjusted EBITDA of $568.5M up 10% Y/Y; adjusted EBITDA margin on fee revenue of 21.4%.</li><li>Americas revenue (largest segment) up 6% in Q4; Asia-Pacific revenue (fastest growing) up 22%, or 19% in local currency. EMEA revenue rose 6%, but fell 3% in U.S. dollars thanks mostly to the decline in the pound. U.K. revenue rose 8% in pounds amid the post-Brexit vote fallout.</li><li>2017 adjusted EPS is guided to $2.35-$2.45 per share (the midpoint would be 4.3% growth over 2016). This includes expectations for a $0.06 per share hit from forex movements.</li><li><a href=\"http://ir.cbre.com/phoenix.zhtml?c=176560&amp;p=irol-irhome\" target=\"_blank\">Earnings call presentation slides</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3242451-cb-richard-beats-0_13-misses-revenue\" target=\"_blank\">CB Richard beats by $0.13, misses on revenue</a> (Feb. 10)</li><li>CBG&nbsp;<font color='green'>+9%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3242594\" data-linked=\"CBRE Group +9% after big earnings beat\" data-tweet=\"$CBRE - CBRE Group +9% after big earnings beat https://seekingalpha.com/news/3242594-cbre-groupplus-9-after-big-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3242594-cbre-groupplus-9-after-big-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242590\" data-ts=\"1486745520\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242590-nielsen-adds-public-policy-vet-rawlinson-to-board\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen adds public-policy vet Rawlinson to board</a></h4><ul>   <li>Nielsen (<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a> <font color='green'>+2.3%</font>) has added U.S. executive-branch veteran <a href=\"https://seekingalpha.com/pr/16739219-david-rawlinson-joins-nielsen-board-directors\" target=\"_blank\">David Rawlinson</a> to its board.</li>    <li>Rawlinson served in an economic policy role with both the Bush and Obama Administrations. He's currently president of Online Business for W.W. Grainger.</li>    <li>Since 2014, he's served on the board for MonotaRO, Grainger's publicly traded online business in Japan. He'll serve on the audit committee at Nielsen.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242590\" data-linked=\"Nielsen adds public-policy vet Rawlinson to board\" data-tweet=\"$NLSN - Nielsen adds public-policy vet Rawlinson to board https://seekingalpha.com/news/3242590-nielsen-adds-public-policy-vet-rawlinson-to-board?source=tweet\" data-url=\"https://seekingalpha.com/news/3242590-nielsen-adds-public-policy-vet-rawlinson-to-board\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242588\" data-ts=\"1486745244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242588-goldman-sachs-reaffirms-twitter-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman Sachs reaffirms Twitter at Buy</a></h4><ul><li>With sentiment broadly turning lower on Twitter following its reporting of&nbsp;<a href=\"https://seekingalpha.com/news/3242056-twitter-minus-10-percent-q4-2016-results-mixed-revenue-growth-1-percent\" target=\"_blank\">1% revenue growth in Q4 2016</a> and issuance of negatively implied outlook, analyst Heath Terry maintains confidence, though reduces target from $22 to $20.</li><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Twitter%2C+Inc.+%28TWTR%29+PT+Lowered+to+%2420+at+Goldman+Sachs%2C+Sees+Significant+Value+In+User+Base/12524177.html\" target=\"_blank\">Notes</a>: \"We continue to see significant value in Twitter&rsquo;s user base, engagement, data and content. With TWTR trading at 19.6X 2017E EV/EBITDA vs. the sector at 13X, modestly accelerating user engagement, potential for margin recovery post restructuring, and M&amp;A optionality we see the risk/reward as favorable and remain Buy rated.\"</li><li>Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) $15.68,&nbsp;<font color='red'>-4.45%</font>.</li><li>Previously (February 9, 2017):&nbsp;<a href=\"https://seekingalpha.com/news/3242217-twitter-downgraded-underperform-cowen-company-raymond-james\" target=\"_blank\">Twitter downgraded to Underperform at Cowen and Company, Raymond James</a></li><li>Previously (February 9, 2017): <a href=\"https://seekingalpha.com/news/3242185-twitter-target-reduced-10-morgan-stanley\" target=\"_blank\">Twitter target reduced to $10 at Morgan Stanley</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242588\" data-linked=\"Goldman Sachs reaffirms Twitter at Buy\" data-tweet=\"$TWTR - Goldman Sachs reaffirms Twitter at Buy https://seekingalpha.com/news/3242588-goldman-sachs-reaffirms-twitter-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3242588-goldman-sachs-reaffirms-twitter-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242574\" data-ts=\"1486743788\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242574-nvidia-reiterated-hold-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia reiterated at Hold at Stifel</a></h4><ul><li>Notable amid several confident reiterations and target raises to levels $130+ (<a href=\"http://www.streetinsider.com/Analyst+Comments/NVIDIA+%28NVDA%29+PT+Raised+to+%24130+at+Canaccord+Genuity+Following+4Q/12525904.html\" target=\"_blank\">Canaccord Genuity</a>,&nbsp;<a href=\"http://www.streetinsider.com/Analyst+Comments/NVIDIA+%28NVDA%29+PT+Raised+to+%24132+at+UBS+Following+4Q+Report/12525524.html\" target=\"_blank\">UBS</a>,&nbsp;<a href=\"http://www.streetinsider.com/Analyst+Comments/NVIDIA+%28NVDA%29+PT+Raised+to+%24140+at+Jefferies+Following+7th+Consecutive+Beat/12524741.html\" target=\"_blank\">Jefferies</a>,&nbsp;<a href=\"http://www.streetinsider.com/Analyst+Comments/NVIDIA+%28NVDA%29+PT+Raised+to+%24130+at+RBC+Capital/12524173.html\" target=\"_blank\">RBC Capital Markets</a>,&nbsp;<a href=\"http://www.streetinsider.com/Analyst+Comments/NVIDIA+%28NVDA%29+PT+Raised+to+%24130+at+Mizuho+Securities/12524172.html\" target=\"_blank\">Mizuho Securities</a>) and bullish commentary elsewhere (<a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Reiterates+Buy+Rating+on+NVIDIA+%28NVDA%29+on+Data+Center+Business/12524250.html\" target=\"_blank\">Needham &amp; Company</a>,&nbsp;<a href=\"http://www.streetinsider.com/Analyst+Comments/NVIDIA+%28NVDA%29+PT+Raised+to+%24100+at+Instinet%3B+Datacenter+Main+Driver+in+4Q/12524762.html\" target=\"_blank\">Instinet</a>) following Nvidia's (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) positive Q4 2017 and outlook,&nbsp;Stifel&nbsp;<a href=\"http://www.streetinsider.com/Analyst+Comments/NVIDIA+%28NVDA%29+PT+Raised+to+%2490+at+Stifel%3B+%22Record+Revenue%22+Across+Platforms/12525650.html\" target=\"_blank\">analyst Kevin Cassidy</a>&nbsp;similarly commends the quarter, though maintains position on valuation.</li><li>Increases target from $76 to $90 (current price $114.38,&nbsp;<font color='red'>-1.72%</font>).</li><li>Previously (February 9, 2017):&nbsp;<a href=\"https://seekingalpha.com/news/3242234-nvidia-minus-2_05-percent-q4-2017-revenue-outlook-estimates\" target=\"_blank\">Nvidia -2.05%; Q4 2017, revenue outlook over estimates</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242574\" data-linked=\"Nvidia reiterated at Hold at Stifel\" data-tweet=\"$NVDA - Nvidia reiterated at Hold at Stifel https://seekingalpha.com/news/3242574-nvidia-reiterated-hold-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3242574-nvidia-reiterated-hold-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242571\" data-ts=\"1486743179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UBNT\" target=\"_blank\">UBNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242571-ubiquitiminus-14_8-credit-suisse-cuts-to-underperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ubiquiti -14.8%; Credit Suisse cuts to Underperform</a></h4><ul>   <li>Ubiquiti Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/UBNT' title='Ubiquiti Networks, Inc.'>UBNT</a>) is <font color='red'>14.8% lower</font> and hitting its lowest point since October following <a href=\"https://seekingalpha.com/news/3242227-ubiquiti-networks-misses-0_05-beats-revenue\" target=\"_blank\">fiscal Q2 earnings</a> where it missed profits as gross margins were pressed by its product mix and expedited holiday 2016 shipping costs.</li>    <li>Credit Suisse has cut the shares to Underperform, noting shares look pricey compared to peers and that margins may be peaking and face further pressure as Ubiquiti invests more in research and development.</li>    <li>Analyst Kulbinder Garcha is also pointing to other issues: The company lacks a CFO and changed auditors last year, raising control concerns, and it's subject to the recent lawsuit by Synopsys claiming Ubiquiti used its software thousands of times with counterfeit keys rather than paying for a license.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242571\" data-linked=\"Ubiquiti -14.8%; Credit Suisse cuts to Underperform\" data-tweet=\"$UBNT $UI - Ubiquiti -14.8%; Credit Suisse cuts to Underperform https://seekingalpha.com/news/3242571-ubiquitiminus-14_8-credit-suisse-cuts-to-underperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3242571-ubiquitiminus-14_8-credit-suisse-cuts-to-underperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>106&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242570\" data-ts=\"1486743082\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242570-big-jobs-numbers-out-of-canada-loonie-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big jobs numbers out of Canada; loonie gains</a></h4><ul><li><a href=\"http://www.statcan.gc.ca/daily-quotidien/170210/dq170210a-eng.htm?HPA=1\" target=\"_blank\">Canada added 48K jobs</a> in January, blowing away estimates for just 10K. The unemployment rate ticked down to 6.8% vs. expectations for a flat read at 6.9%.</li><li>After a rough 2015 and most of 2016, job growth up north has been strong for five of the last six months.</li><li>Glass half-empty types will note <a href=\"http://www.theglobeandmail.com/report-on-business/economy/canada-jobs/article33978364/\" target=\"_blank\">the continuing surge</a> in part-time work - over the last year, part-time positions have increased by 190K, while full-time has fallen by 86K.</li><li>\"This will keep alive concerns that Canada&rsquo;s economy is not generating the 'right' types of jobs,\" says RBC's&nbsp;Dawn Desjardins.</li><li>The loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>) is&nbsp;<font color='green'>higher by 0.5%</font>&nbsp;vs. the greenback and buying $0.7647. Stocks (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>) in Toronto are&nbsp;<font color='green'>up 0.5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242570\" data-linked=\"Big jobs numbers out of Canada; loonie gains\" data-tweet=\"$FXC $EWC - Big jobs numbers out of Canada; loonie gains https://seekingalpha.com/news/3242570-big-jobs-numbers-out-of-canada-loonie-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3242570-big-jobs-numbers-out-of-canada-loonie-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242547\" data-ts=\"1486742493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242547-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='green'>+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TCON' title='Tracon Pharmaceuticals'>TCON</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/PDEX' title='Pro-Dex, Inc.'>PDEX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology'>MYOS</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/BTX' title='BioTime, Inc'>BTX</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242547\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$GBSN-OLD $PLSE $IMMU - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3242547-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3242547-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242561\" data-ts=\"1486741208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242561-activision-blizzardplus-16_1-to-new-highs-after-record-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Activision Blizzard +16.1% to new highs after record quarter</a></h4><ul>   <li>Activision Blizzard (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>) is <font color='green'>up 16.1%</font> to all-time highs after a <a href=\"https://seekingalpha.com/news/3242328-activision-blizzard-plus-8_9-percent-earnings-raised-dividend-buyback\" target=\"_blank\">record Q4 report</a> where the company beat expectations and added a new $1B buyback program along with a higher dividend.</li>    <li>Guidance for the coming year is probably conservative, analysts suggest.</li>    <li>Jefferies analyst Tim O'Shea has one of the most bullish price targets at $55, implying another 19% upside. The company beat despite sales declines at its cash cow <i>Call of Duty</i> franchise; more evidence that initial sell-in isn't as important as before, he says.</li>    <li>The company has tough 2017 comps in Blizzard, says UBS analyst Eric Sheridan, but a positive ramp is coming with a new <i>Destiny</i> in September, and a return to form for <i>Call of Duty</i> could provide second-half growth as well. He's boosted his price target to $48 from $45.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242561\" data-linked=\"Activision Blizzard +16.1% to new highs after record quarter\" data-tweet=\"$ATVI - Activision Blizzard +16.1% to new highs after record quarter https://seekingalpha.com/news/3242561-activision-blizzardplus-16_1-to-new-highs-after-record-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3242561-activision-blizzardplus-16_1-to-new-highs-after-record-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242557\" data-ts=\"1486740365\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MT\" target=\"_blank\">MT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242557-arcelormittalplus-5-q4-swings-to-profit-sees-higher-demand-in-u-s-brazil\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArcelorMittal +5% as Q4 swings to profit; sees higher demand in U.S., Brazil</a></h4><ul>     <li>ArcelorMittal (<a href='https://seekingalpha.com/symbol/MT' title='ArcelorMittal'>MT</a> <font color='green'>+5.2%</font>) is ~5% higher after reporting net <a href=\"https://seekingalpha.com/news/3242412-arcelormittal-reports-q4-results\" target=\"_blank\">Q4 earnings</a> of $403M helped by improved costs, compared with a $6.69B loss in the year-ago quarter, and <a href=\"https://www.wsj.com/articles/BT-CO-20170210-704643\" target=\"_blank\">expressing optimism</a> about 2017 and the potential impact of Pres. Trump's proposals on the company.</li>     <li>CEO Lakshmi Mittal says Trump's promises to invest in U.S. infrastructure and manufacturing are \"good for us\" as well as the steel industry at large, and thinks Trump could promote strong trade actions against a glut of Chinese steel on the global market.</li><li>MT says year-end net debt stood at $11.1B, down from $15.7B at the end of  2015 and now at the lowest since the  creation of the company a decade ago.</li>     <li>MT says it expects to increase 2017 capex to $2.9B from $2.4B last year due to recovering steel markets; it sees apparent steel consumption - which takes  into account inventory changes - for the market to <a href=\"http://www.reuters.com/article/us-arcelormittal-results-idUSKBN15P0KL\" target=\"_blank\">rise by up to 4% in the U.S. and in Brazil</a> in 2017 after declines last  year, with Chinese declining by as much as 1%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242557\" data-linked=\"ArcelorMittal +5% as Q4 swings to profit; sees higher demand in U.S., Brazil\" data-tweet=\"$MT - ArcelorMittal +5% as Q4 swings to profit; sees higher demand in U.S., Brazil https://seekingalpha.com/news/3242557-arcelormittalplus-5-q4-swings-to-profit-sees-higher-demand-in-u-s-brazil?source=tweet\" data-url=\"https://seekingalpha.com/news/3242557-arcelormittalplus-5-q4-swings-to-profit-sees-higher-demand-in-u-s-brazil\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242554\" data-ts=\"1486739364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CERN\" target=\"_blank\">CERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242554-cerner-q4-top-line-up-7-earnings-down-10-cash-flow-ops-down-6-shares-ease-4-on-conservative\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cerner Q4 top line up 7%; earnings down 10%; cash flow ops down 6%; shares ease 4% on conservative EPS guidance</a></h4><ul><li>Cerner (<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a> <font color='red'>-4.1%</font>) <a href=\"https://seekingalpha.com/pr/16738778-cerner-reports-fourth-quarter-full-year-2016-results\" target=\"_blank\">Q4 results</a> ($M): Total Revenues: 1,257.8 (+7.0%); System Sales: 352.3 (-7.8%); Support, Maintenance &amp; Services: 880.5 (+13.5%).</li><li>Net Income: 149.7 (-9.9%); Non-GAAP Net Income: 206.2 (-2.9%); EPS: 0.44 (-8.3%); Non-GAAP EPS: 0.61 (unch); CF Ops: 333.2 (-5.6%).</li><li><strong>2017 Guidance</strong>: Revenues: $5.1B - 5.3B; Non-GAAP EPS: $2.44 - 2.56 (consensus is $2.56).</li><li><strong>Q1 Guidance</strong>: Revenues: $1.200B - 1.275B; Non-GAAP EPS: $0.57 - 0.59; New business bookings: $1.125B - 1.275B.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242554\" data-linked=\"Cerner Q4 top line up 7%; earnings down 10%; cash flow ops down 6%; shares ease 4% on conservative EPS guidance\" data-tweet=\"$CERN - Cerner Q4 top line up 7%; earnings down 10%; cash flow ops down 6%; shares ease 4% on conservative EPS guidance https://seekingalpha.com/news/3242554-cerner-q4-top-line-up-7-earnings-down-10-cash-flow-ops-down-6-shares-ease-4-on-conservative?source=tweet\" data-url=\"https://seekingalpha.com/news/3242554-cerner-q4-top-line-up-7-earnings-down-10-cash-flow-ops-down-6-shares-ease-4-on-conservative\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242543\" data-ts=\"1486737861\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PLSE\" target=\"_blank\">PLSE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242543-former-pharmacyclics-execs-take-17-stake-in-pulse-bio-shares-up-33\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Former Pharmacyclics execs take 17% stake in Pulse Bio; shares up 33%</a></h4><ul><li>Ultra-thinly traded Pulse Biosciences (<a href='https://seekingalpha.com/symbol/PLSE' title='Pulse Biosciences'>PLSE</a> <font color='green'>+32.5%</font>) jumps out of the blocks on increased volume, albeit on turnover of only 19K shares, in response to its <a href=\"https://seekingalpha.com/pr/16739286-pulse-biosciences-announces-healthcare-executives-entrepreneurs-robert-duggan-dr-maky\" target=\"_blank\">announcement </a>that the former CEO and COO of Pharmacyclics, Bob Duggan and Maky Zanganeh, have taken a 17.1% stake in the company. Mr. Duggan owns ~2.1M shares while new board member Zangeneh owns ~279K shares.</li><li>Development-stage Pulse's technology platform is called <a href=\"http://www.pulsebiosciences.com/nano-pulse-stimulation/\" target=\"_blank\">Nano-Pulse Stimulation</a> &#40;NPS&#41;. The company says NPS has potential as a cancer treatment. When NPS is applied directly to tissue it creates a transient opening of small pores in cell and organelle membranes that triggers a signaling cascade within a tumor that leads to cell death.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242543\" data-linked=\"Former Pharmacyclics execs take 17% stake in Pulse Bio; shares up 33%\" data-tweet=\"$PLSE - Former Pharmacyclics execs take 17% stake in Pulse Bio; shares up 33% https://seekingalpha.com/news/3242543-former-pharmacyclics-execs-take-17-stake-in-pulse-bio-shares-up-33?source=tweet\" data-url=\"https://seekingalpha.com/news/3242543-former-pharmacyclics-execs-take-17-stake-in-pulse-bio-shares-up-33\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242537\" data-ts=\"1486736860\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBSN\" target=\"_blank\">GBSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242537-great-basin-initiates-restructuring-plan-50-jobs-cut-36m-convertible-debt-redeemed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Great Basin initiates restructuring plan, 50 jobs cut, $36M convertible debt redeemed</a></h4><ul><li>With the aim of reducing its cash consumption and goosing growth, Great Basin Scientific (NASDAQ:<a href='https://seekingalpha.com/symbol/GBSN-OLD' title='Great Basin Scientific, Inc.'>GBSN</a>) launches a <a href=\"https://www.sec.gov/Archives/edgar/data/1512138/000114420417007228/v458871_ex99-1.htm\" target=\"_blank\">restructuring plan</a> that it says will streamline certain manufacturing and administrative processes. The move involves the elimination of 50 positions nationwide. Annual cash burn should be reduced $10M - 12M.</li><li>Concurrently, the company has agreed to <a href=\"https://www.sec.gov/Archives/edgar/data/1512138/000114420417007227/v458872_8k.htm\" target=\"_blank\">redeem </a>$35.6M of its outstanding 2016 Notes with cash from its restricted accounts. Afterward, the aggregate principal amount of the Notes outstanding will be $36.3M (from $71.8M).</li></ul><div class=\"tiny-share-widget\" data-id=\"3242537\" data-linked=\"Great Basin initiates restructuring plan, 50 jobs cut, $36M convertible debt redeemed\" data-tweet=\"$GBSN $GBSN-OLD - Great Basin initiates restructuring plan, 50 jobs cut, $36M convertible debt redeemed https://seekingalpha.com/news/3242537-great-basin-initiates-restructuring-plan-50-jobs-cut-36m-convertible-debt-redeemed?source=tweet\" data-url=\"https://seekingalpha.com/news/3242537-great-basin-initiates-restructuring-plan-50-jobs-cut-36m-convertible-debt-redeemed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242532\" data-ts=\"1486736259\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242532-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul>     <li><b>Gainers:</b> SHLD <font color='green'>+40%</font>. <a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/BIOL' title='Biolase, Inc.'>BIOL</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SKX' title='Skechers USA Inc.'>SKX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/WRN' title='Western Copper and Gold Corporation'>WRN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/SWIR' title='Sierra Wireless, Inc.'>SWIR</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NE' title='Noble Corporation plc'>NE</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SDRL' title='Seadrill Limited &#40;New&#41;'>SDRL</a> <font color='green'>+5%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TCON' title='Tracon Pharmaceuticals'>TCON</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/YELP' title='Yelp'>YELP</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/IPCI' title='IntelliPharmaCeutics International Inc'>IPCI</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/EGLE' title='Eagle Bulk Shipping Inc.'>EGLE</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/BTX' title='BioTime, Inc'>BTX</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/UBNT' title='Ubiquiti Networks, Inc.'>UBNT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3242532\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$SHLDQ $INFN $BIOL - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3242532-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3242532-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242530\" data-ts=\"1486736160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTX\" target=\"_blank\">BTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242530-biotime-prices-equity-offering-shares-ease-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioTime prices equity offering; shares ease 7% premarket</a></h4><ul><li>BioTime (NYSEMKT:<a href='https://seekingalpha.com/symbol/BTX' title='BioTime, Inc'>BTX</a>) slumps&nbsp;<font color='red'>7%</font>&nbsp;premarket on increased volume in response to the <a href=\"https://seekingalpha.com/pr/16739364-biotime-inc-announces-pricing-public-offering-common-stock\" target=\"_blank\">pricing </a>of its public offering of 6,481,482 shares of common stock at $2.70. Underwriters over-allotment is an additional 972,222 shares. Closing date is February 15. Net proceeds will be used for general corporate purposes.</li><li>Yesterday's close was $3.01.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242530\" data-linked=\"BioTime prices equity offering; shares ease 7% premarket\" data-tweet=\"$BTX $LCTX - BioTime prices equity offering; shares ease 7% premarket https://seekingalpha.com/news/3242530-biotime-prices-equity-offering-shares-ease-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3242530-biotime-prices-equity-offering-shares-ease-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242529\" data-ts=\"1486736063\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLF\" target=\"_blank\">CLF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242529-cliffs-natural-prices-upsized-offering-10_75-macquarie-out-positive\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cliffs Natural prices upsized offering at $10.75, but Macquarie out positive</a></h4><ul><li>Cliffs Natural Resources (NYSE:<a href='https://seekingalpha.com/symbol/CLF' title='Cleveland-Cliffs, Inc.'>CLF</a>) <font color='red'>-4.6%</font>&nbsp;premarket after <a href=\"https://seekingalpha.com/pr/16739076-cliffs-natural-resources-inc-prices-upsized-public-offering-common-shares\" target=\"_blank\">upsizing its public offering</a> by 5M shares and pricing 55M shares at $10.75 each.</li><li>Macquarie analysts <a href=\"https://twitter.com/thenotablecalls/status/830032568628154368\" target=\"_blank\">praise the offering</a>, saying it removes the debt burden, positions the company to grow, and should advance the timetable for making an announcement to enter the DRI market to 2017.</li><li>\"If management's guidance proves to be accurate, we believe the shares may be <a href=\"https://twitter.com/thenotablecalls/status/830032871515619328\" target=\"_blank\">worth as much as $20</a>,\"&nbsp;Macquarie adds.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242529\" data-linked=\"Cliffs Natural prices upsized offering at $10.75, but Macquarie out positive\" data-tweet=\"$CLF - Cliffs Natural prices upsized offering at $10.75, but Macquarie out positive https://seekingalpha.com/news/3242529-cliffs-natural-prices-upsized-offering-10_75-macquarie-out-positive?source=tweet\" data-url=\"https://seekingalpha.com/news/3242529-cliffs-natural-prices-upsized-offering-10_75-macquarie-out-positive\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>25&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242520\" data-ts=\"1486734757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFN\" target=\"_blank\">INFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242520-infinera-target-increased-needham-company-upgraded-to-buy-instinet\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infinera target increased at Needham &amp; Company, upgraded to Buy at Instinet</a></h4><ul><li>Following Infinera's&nbsp;<a href=\"https://seekingalpha.com/news/3242403-infinera-plus-8_51-percent-q4-2016-expectations\" target=\"_blank\">Q4 2016 reporting</a>&nbsp;(<a href=\"https://seekingalpha.com/article/4044714-infinera-infn-q4-2016-results-earnings-call-transcript?part=single\" target=\"_blank\">earnings call transcript</a>), <a href=\"http://www.streetinsider.com/Analyst+Comments/Infinera+Corp.+%28INFN%29+PT+Raised+to+%2413.50+at+Needham+%26+Company/12524645.html\" target=\"_blank\">analyst Alex Henderson</a> (Needham &amp; Company) reiterates at Strong Buy, noting firm was too early in calling the rating originally, though observes \"that the company has troughed, estimates have bottomed out and that INFN is poised to rebound results,\" and considers it at this point more suitable. Target from $12.50 prior.</li><li><a href=\"http://www.streetinsider.com/Analyst+Comments/Instinet+Upgrades+Infinera+Corp.+%28INFN%29+to+Buy/12524844.html\" target=\"_blank\">Analyst Keffrey Kvaal</a>&nbsp;(Instinet): \"1Q guidance was in line with to below consensus estimates&mdash;disappointing, given that it was INFN&rsquo;s fourth straight guide down and 4Q ended up fine. However, strengthening in Europe/webscale and a solidifying product roadmap lend visibility to sequential growth through 2017.\" Raises target from $8 to $15, rating from Neutral.</li><li>Infinera (NASDAQ:<a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a>) $10.80,&nbsp;<font color='green'>+14.89%</font>&nbsp;pre-market.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242520\" data-linked=\"Infinera target increased at Needham &amp; Company, upgraded to Buy at Instinet\" data-tweet=\"$INFN - Infinera target increased at Needham &amp; Company, upgraded to Buy at Instinet https://seekingalpha.com/news/3242520-infinera-target-increased-needham-company-upgraded-to-buy-instinet?source=tweet\" data-url=\"https://seekingalpha.com/news/3242520-infinera-target-increased-needham-company-upgraded-to-buy-instinet\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242518\" data-ts=\"1486734522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242518-shortened-timeline-for-intercepts-late-stage-study-of-oba-in-nash-stokes-investors-shares-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shortened timeline for Intercept&#39;s late-stage study of OBA in NASH stokes investors, shares up 11% premarket</a></h4><ul><li>In an update to investors, Intercept Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>) announces that it has changed the protocol, based on discussion with the FDA, in its Phase 3 <a href=\"https://clinicaltrials.gov/ct2/show/NCT02548351?term=intercept+pharmaceuticals&amp;rank=11\" target=\"_blank\">REGENERATE </a>study that should accelerate its completion and enhance the prospects for a positive outcome.</li><li>The changes include a new primary endpoint of fibrosis improvement or NASH resolution (previously both) and a reduction in target enrollment to 750 subjects from ~2,000 (to be completed mid-year).</li><li>Shares are up&nbsp;<font color='green'>11%</font>&nbsp;premarket on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242518\" data-linked=\"Shortened timeline for Intercept&#39;s late-stage study of OBA in NASH stokes investors, shares up 11% premarket\" data-tweet=\"$ICPT - Shortened timeline for Intercept&#39;s late-stage study of OBA in NASH stokes investors, shares up 11% premarket https://seekingalpha.com/news/3242518-shortened-timeline-for-intercepts-late-stage-study-of-oba-in-nash-stokes-investors-shares-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3242518-shortened-timeline-for-intercepts-late-stage-study-of-oba-in-nash-stokes-investors-shares-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242512\" data-ts=\"1486734122\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPCI\" target=\"_blank\">IPCI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242512-intellipharmaceutics-reports-fy16-results-shares-off-10-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IntelliPharmaCeutics reports FY16 results; shares off 10% premarket</a></h4><ul><li>IntelliPharmaCeutics (<a href='https://seekingalpha.com/symbol/IPCI' title='IntelliPharmaCeutics International Inc'>IPCI</a>) <a href=\"https://seekingalpha.com/pr/16739254-intellipharmaceutics-announces-2016-year-end-results\" target=\"_blank\">FY16 results</a>: Revenues: $2.2M (-46.3%); Operating Loss: ($9.9M) (-39.4%); Net Loss: ($10.1M) (-36.5%); Loss Per Share: ($0.38) (-22.6%); Quick Assets: $4.1M (+127.8%); CF Ops: ($6.3M) (-65.8%).</li><li>No guidance given.</li><li>Shares are down&nbsp;<font color='red'>10.07%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242512\" data-linked=\"IntelliPharmaCeutics reports FY16 results; shares off 10% premarket\" data-tweet=\"$IPCI - IntelliPharmaCeutics reports FY16 results; shares off 10% premarket https://seekingalpha.com/news/3242512-intellipharmaceutics-reports-fy16-results-shares-off-10-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3242512-intellipharmaceutics-reports-fy16-results-shares-off-10-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242510\" data-ts=\"1486733897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/G\" target=\"_blank\">G</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242510-on-genpacts-q4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Genpact&#39;s Q4</a></h4><ul>     <li>Genpact (NYSE:<a href='https://seekingalpha.com/symbol/G' title='Genpact Limited'>G</a>)&nbsp;reports revenue rose 7% on a constant currency basis in <a href=\"https://seekingalpha.com/pr/16739190-genpact-reports-full-year-fourth-quarter-2016-results\" target=\"_blank\">Q4</a>.</li>     <li>Global Client revenue grew 9% to $576M (~+11% on a constant currency basis).</li>     <li>GE revenue down 10% to $106M.</li>     <li>New bookings up 3% Y/Y to $2.65B.</li>     <li>Gross margin rate improved 120 bps to 40.3%.</li>     <li>Adjusted operating margin rate expanded 190 bps to 16.7%.</li>     <li>The company repurchased 4.3M shares during the quarter.</li>     <li><b>FY2017 Guidance</b>: Total revenue: $2.61B to $2.68B (+2% to +4%); Global Client revenue: +4% to +7% (5% to 8% on a constant currency basis); Adjusted operating margin rate: 15.7%; Adjusted EPS: $1.53 to $1.57.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3242510\" data-linked=\"More on Genpact&#39;s Q4\" data-tweet=\"$G - More on Genpact&#39;s Q4 https://seekingalpha.com/news/3242510-on-genpacts-q4?source=tweet\" data-url=\"https://seekingalpha.com/news/3242510-on-genpacts-q4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242508\" data-ts=\"1486733733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FCX\" target=\"_blank\">FCX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242508-freeportplus-4-indonesia-reportedly-issues-new-mining-permit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freeport +4% as Indonesia reportedly issues new mining permit</a></h4><ul>     <li>Freeport McMoRan (NYSE:<a href='https://seekingalpha.com/symbol/FCX' title='Freeport-McMoRan Inc.'>FCX</a>) <font color='green'>+4.1%</font> premarket after Indonesia reportedly <a href=\"https://en.tempo.co/read/news/2017/02/10/055845194/Freeport-Special-Mining-Permit-to-be-Ratified-Today\" target=\"_blank\">issued a special mining permit</a> to the company's local unit, citing an official at the country's mining ministry.</li>     <li>With the new permits, FCX could apply immediately for a resumption to exports that were stopped on Jan. 12.</li><li>FCX has been threatening to cut production at its Grasberg copper mine, the world's biggest; Freeport Indonesia employs 32K people.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/JJC' title='iPath Series B Bloomberg Copper Subindex Total Return ETN'>JJC</a>, <a href='https://seekingalpha.com/symbol/CPER' title='United States Copper Index ETF'>CPER</a>, <a href='https://seekingalpha.com/symbol/CUPM' title='iPath Pure Beta Copper ETN'>CUPM</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242508\" data-linked=\"Freeport +4% as Indonesia reportedly issues new mining permit\" data-tweet=\"$FCX $FCX $JJCTF - Freeport +4% as Indonesia reportedly issues new mining permit https://seekingalpha.com/news/3242508-freeportplus-4-indonesia-reportedly-issues-new-mining-permit?source=tweet\" data-url=\"https://seekingalpha.com/news/3242508-freeportplus-4-indonesia-reportedly-issues-new-mining-permit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242499\" data-ts=\"1486732595\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242499-sell-side-cant-bail-fast-enough-on-twitter-down-another-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-side can&#39;t bail fast enough on Twitter; down another 2% premarket</a></h4><ul><li>In addition to a number of downgrades and price target cuts <a href=\"https://seekingalpha.com/news/3242217-twitter-downgraded-underperform-cowen-company-raymond-james\" target=\"_blank\">which took place</a> in the immediate aftermath of yesterday's disappointing Q4 results, another four sell-siders have thrown in the towel ahead of today's open.</li><li>Atlantic's James Cordwell cuts to Underweight with $13 PT reduced from $16.</li><li>Loop Capital's Blake Harper downgrades to Sell with $10 PT reduced from $16.</li><li>Deutsche cuts to Hold, citing \"substantial challenges\" in the ad business and stagnant MAU growth \"despite massive publicity of late.\"</li><li>Citi downgrades to Sell.</li><li><a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>&nbsp;<font color='red'>-2%</font>&nbsp;premarket to $16.08.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242499\" data-linked=\"Sell-side can&#39;t bail fast enough on Twitter; down another 2% premarket\" data-tweet=\"$TWTR - Sell-side can&#39;t bail fast enough on Twitter; down another 2% premarket https://seekingalpha.com/news/3242499-sell-side-cant-bail-fast-enough-on-twitter-down-another-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3242499-sell-side-cant-bail-fast-enough-on-twitter-down-another-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>61&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242497\" data-ts=\"1486732516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FLR\" target=\"_blank\">FLR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242497-fluor-guides-q4-earnings-above-consensus-sharesplus-3_3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fluor guides Q4 earnings above consensus, shares +3.3% premarket</a></h4><ul><li>Fluor (NYSE:<a href='https://seekingalpha.com/symbol/FLR' title='Fluor Corporation'>FLR</a>) <font color='green'>+3.3%</font> premarket after issuing <a href=\"https://seekingalpha.com/pr/16739174-fluor-announces-preliminary-fourth-quarter-results\" target=\"_blank\">upbeat Q4 earnings guidance</a>, seeing adjusted EPS from continuing operations of $0.82 vs. $0.79 analyst consensus estimate.</li><li>FLR says it will take a $0.32/share non-cash charge in Q4, due to new IRS rules that limit the  deductibility of foreign currency translation losses in certain foreign  subsidiaries; the $0.82 does not include the adjustment.</li><li>FLR reaffirms FY 2017 EPS guidance of $2.75-$3.25 vs $2.96 consensus; the company will report official Q4 results on  Feb. 17.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242497\" data-linked=\"Fluor guides Q4 earnings above consensus, shares +3.3% premarket\" data-tweet=\"$FLR - Fluor guides Q4 earnings above consensus, shares +3.3% premarket https://seekingalpha.com/news/3242497-fluor-guides-q4-earnings-above-consensus-sharesplus-3_3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3242497-fluor-guides-q4-earnings-above-consensus-sharesplus-3_3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242493\" data-ts=\"1486732053\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ICPT\" target=\"_blank\">ICPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242493-intercept-pharma-to-update-investors-on-late-stage-oca-study-in-nash-shares-down-11-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intercept Pharma to update investors on late-stage OCA study in NASH; shares down 11% premarket</a></h4><ul><li>Investors appear a bit skittish over Intercept Pharmaceuticals' (NASDAQ:<a href='https://seekingalpha.com/symbol/ICPT' title='Intercept Pharmaceuticals'>ICPT</a>) <a href=\"https://seekingalpha.com/pr/16739195-intercept-provide-update-phase-3-regenerate-trial-obeticholic-acid-treatment-nash-patients\" target=\"_blank\">announcement </a>of an update at 8:30 am ET on its Phase 3 REGENERATE study assessing lead product candidate OCALIVA (obeticholic acid) in NASH patients with liver fibrosis. Shares are down&nbsp;<font color='red'>11%</font>&nbsp;on average volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242493\" data-linked=\"Intercept Pharma to update investors on late-stage OCA study in NASH; shares down 11% premarket\" data-tweet=\"$ICPT - Intercept Pharma to update investors on late-stage OCA study in NASH; shares down 11% premarket https://seekingalpha.com/news/3242493-intercept-pharma-to-update-investors-on-late-stage-oca-study-in-nash-shares-down-11-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3242493-intercept-pharma-to-update-investors-on-late-stage-oca-study-in-nash-shares-down-11-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242492\" data-ts=\"1486731966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242492-sears-soars-nearly-20-on-restructuring-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sears soars nearly 20% on restructuring plans</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/16739212-sears-holdings-outlines-next-phase-strategic-transformation\" target=\"_blank\">Plans include</a> at least $1B of annualized cost savings by reducing corporate overhead, more closely integrating Sears and Kmart operations, and improving merchandising, supply chain, and inventory management.</li><li>The $1B in savings include those from previously announced closings of 108 Kmarts and 42 Sears stores.</li><li>Proceeds from the Craftsman sale and real estate transactions, along with hoped-for improved operating performance will be used to cut debt. The target is for a reduction in debt and pension obligations of $1.5B in fiscal 2017.</li><li>Q4 comp sales were down 10.3%, with an 8% decline at Kmart and 12.3% at Sears Domestic. Preliminary adjusted EBITDA of negative $61M vs. negative $137M a year ago.</li><li>SHLD&nbsp;<font color='green'>+19.5%&nbsp;</font>premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3242492\" data-linked=\"Sears soars nearly 20% on restructuring plans\" data-tweet=\"$SHLDQ - Sears soars nearly 20% on restructuring plans https://seekingalpha.com/news/3242492-sears-soars-nearly-20-on-restructuring-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3242492-sears-soars-nearly-20-on-restructuring-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>60&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242491\" data-ts=\"1486731901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXL\" target=\"_blank\">AXL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242491-american-axle-and-amp-manufacturing-beats-0_10-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Axle &amp;amp; Manufacturing beats by $0.10, misses on revenue</a></h4><ul><li>American Axle &amp; Manufacturing (NYSE:<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a>): Q4 EPS of $0.78 <font color='green'>beats by $0.10</font>.</li><li>Revenue of $946.5M (-1.2% Y/Y) <font color='red'>misses by $10.45M</font>.</li><li>Shares <font color='green'>+3.54%</font> PM.</li><li><a href='https://seekingalpha.com/pr/16739247-aam-reports-fourth-quarter-full-year-2016-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242491\" data-linked=\"American Axle &amp;amp; Manufacturing beats by $0.10, misses on revenue\" data-tweet=\"$AXL - American Axle &amp; Manufacturing beats by $0.10, misses on revenue https://seekingalpha.com/news/3242491-american-axle-and-amp-manufacturing-beats-0_10-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3242491-american-axle-and-amp-manufacturing-beats-0_10-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242481\" data-ts=\"1486730993\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSTG\" target=\"_blank\">BSTG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242481-biostage-prices-equity-offering-shares-down-37-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biostage prices equity offering; shares down 37% premarket</a></h4><ul><li>Thinly traded nano cap Biostage (<a href='https://seekingalpha.com/symbol/BSTG' title='Biostage, Inc.'>OTC:BSTG</a>) slumps&nbsp;<font color='red'>37%</font>&nbsp;premarket on robust volume in response to the <a href=\"https://seekingalpha.com/pr/16739184-biostage-announces-8_0-million-public-offering\" target=\"_blank\">pricing </a>of its public offering of 20M shares of common stock at $0.40. Closing date is February 15.</li><li>Yesterday's close was $0.5066.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242481\" data-linked=\"Biostage prices equity offering; shares down 37% premarket\" data-tweet=\"$BSTG - Biostage prices equity offering; shares down 37% premarket https://seekingalpha.com/news/3242481-biostage-prices-equity-offering-shares-down-37-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3242481-biostage-prices-equity-offering-shares-down-37-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242438\" data-ts=\"1486730045\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OCUL\" target=\"_blank\">OCUL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242438-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Ocular Therapeutix (NASDAQ:<a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a>) initiated with Overweight rating and $35 (387% upside) price target by Cantor Fitzgerald. Shares up&nbsp;<font color='green'>7%</font>&nbsp;premarket on average volume.</li><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) downgraded to Underperform from Neutral with a $27 (16% downside risk) price target by Mizuho Securities. Shares down&nbsp;<font color='red'>1%</font>&nbsp;premarket on average volume.</li><li>Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) downgraded to Market Perform from Outperform by Oppenheimer. Downgraded to Market Perform with $45 (16% downside risk) price target by Avondale. Canaccord Genuity reiterates Buy rating and $59 (10% upside) price target. Shares down&nbsp;<font color='red'>6%</font>&nbsp;premarket on light volume.</li><li>TESARO (NASDAQ:<a href='https://seekingalpha.com/symbol/TSRO' title='Tesaro'>TSRO</a>) price target increased to $232 (24% upside) from $151 by Citigroup. Buy rating and $190 (2% upside) price target reiterated by SunTrust Robinson Humphrey. Downgraded to Market Perform with $186 (0% upside) price target by Leerink Swann. Shares up a fraction premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242438\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$OCUL $OCUL $TEVA - Premarket analyst action - healthcare https://seekingalpha.com/news/3242438-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3242438-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242472\" data-ts=\"1486729668\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPG\" target=\"_blank\">IPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242472-interpublic-groupplus-3-after-earnings-beat-boosts-to-dividend-and-buyback\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpublic Group +3% after earnings beat, boosts to dividend and buyback</a></h4><ul><li>Q4 earnings (ex-items) of $303.6M or $0.75 per share, up from $0.66 earned a year ago, and ahead of expectations for $0.67.</li><li>Quarterly dividend is boosted 20% to $0.18 per share, bringing the annualized yield to 3.1%.</li><li>4.8M shares repurchased in Q4 for $110M, or average cost of $22.90 each. Full-year buybacks were 13.3M shares for $303.3M, or average cost of $22.76 each.</li><li>New buyback program of up to $300M of stock is authorized.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3242465-interpublic-group-companies-beats-0_08-revenue-line\" target=\"_blank\">Interpublic Group of Companies beats by $0.08,  revenue in-line</a> (Feb. 10)</li><li><a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>&nbsp;<font color='green'>+3.1%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3242472\" data-linked=\"Interpublic Group +3% after earnings beat, boosts to dividend and buyback\" data-tweet=\"$IPG - Interpublic Group +3% after earnings beat, boosts to dividend and buyback https://seekingalpha.com/news/3242472-interpublic-groupplus-3-after-earnings-beat-boosts-to-dividend-and-buyback?source=tweet\" data-url=\"https://seekingalpha.com/news/3242472-interpublic-groupplus-3-after-earnings-beat-boosts-to-dividend-and-buyback\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242466\" data-ts=\"1486729128\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMMU\" target=\"_blank\">IMMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242466-immunomedics-up-28-premarket-on-license-deal-seattle-genetics-for-lead-product-candidate\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Immunomedics up 28% premarket on license deal with Seattle Genetics for lead product candidate IMMU-132 valued as high as $2B</a></h4><ul><li>Immunomedics (NASDAQ:<a href='https://seekingalpha.com/symbol/IMMU' title='Immunomedics, Inc.'>IMMU</a>) jumps&nbsp;<font color='green'>28%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/16739175-immunomedics-enters-exclusive-global-licensing-agreement-seattle-genetics-sacituzumab\" target=\"_blank\">announcement </a>that it has entered into an exclusive global licensing agreement with Seattle Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a>) for lead product product candidate IMMU-132 (sacituzumab govitecan).</li><li>SGEN will be responsible for initiating the Phase 3 study of IMMU-132 in triple-negative breast cancer and submitting the marketing application to the FDA. Other indications that will be pursued include urothelial cancer, small-cell lung cancer and non-small cell lung cancer.</li><li>Under the terms of the agreement, IMMU will receive an upfront payment of $250M, an additional $50M related to rights outside of the U.S., Canada and EU, up to $1.7B in milestones and tiered double-digit royalties on net sales. IMMU retains the right to co-promote IMMU-132 in the U.S. subject to conditions.</li><li>SGEN has also made an equity investment in IMMU via the purchase of 3M common shares at $4.90. The investment includes a three-year warrant to purchase 8,655,804 common shares at the same price.</li><li><a href=\"http://www.immunomedics.com/immu132.shtml\" target=\"_blank\">IMMU-132</a>&nbsp;is an antibody-drug conjugate consisting of an monoclonal antibody that binds to a protein found on the surface of many types of cancer cells called&nbsp;<a href=\"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3201164/\" target=\"_blank\">TROP-2</a>. Specifically binding to the cancer cell enables the precise delivery of the cytotoxic payload, SN-38 (govitecan), the active metabolite of the chemo agent irinotecan. Its value proposition is the ability to deliver the drug over repeated cycles of therapy since govitecan is less toxic than other chemotherapies.</li><li>Management will host a conference call this morning at 8:00 am ET to discuss the deal.</li><li>SGEN is down&nbsp;<font color='red'>6%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242466\" data-linked=\"Immunomedics up 28% premarket on license deal with Seattle Genetics for lead product candidate IMMU-132 valued as high as $2B\" data-tweet=\"$IMMU $IMMU $SGEN - Immunomedics up 28% premarket on license deal with Seattle Genetics for lead product candidate IMMU-132 valued as high as $2B https://seekingalpha.com/news/3242466-immunomedics-up-28-premarket-on-license-deal-seattle-genetics-for-lead-product-candidate?source=tweet\" data-url=\"https://seekingalpha.com/news/3242466-immunomedics-up-28-premarket-on-license-deal-seattle-genetics-for-lead-product-candidate\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242465\" data-ts=\"1486729056\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPG\" target=\"_blank\">IPG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242465-interpublic-group-of-companies-beats-0_08-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Interpublic Group of Companies beats by $0.08,  revenue in-line</a></h4><ul><li>Interpublic Group of Companies (NYSE:<a href='https://seekingalpha.com/symbol/IPG' title='Interpublic Group of Companies Inc.'>IPG</a>): Q4 EPS of $0.75 <font color='green'>beats by $0.08</font>.</li><li>Revenue of $2.26B (+2.7% Y/Y) in-line.</li><li>Shares <font color='green'>+3.09%</font> PM.</li><li><a href='http://investors.interpublic.com/phoenix.zhtml?c=87867&p=earningsdisclosure&erid=807973&vs=txt&id=2245097'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3242465\" data-linked=\"Interpublic Group of Companies beats by $0.08,  revenue in-line\" data-tweet=\"$IPG - Interpublic Group of Companies beats by $0.08, revenue in-line https://seekingalpha.com/news/3242465-interpublic-group-of-companies-beats-0_08-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3242465-interpublic-group-of-companies-beats-0_08-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:17 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3242448\" data-ts=\"1486727354\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCON\" target=\"_blank\">TCON</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3242448-tracon-pharmas-lead-product-candidate-flunks-mid-stage-study-in-brain-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TRACON Pharma&#39;s lead product candidate flunks mid-stage study in brain cancer</a></h4><ul><li>Thinly traded nano cap TRACON Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/TCON' title='Tracon Pharmaceuticals'>TCON</a>) is poised for an ugly day today on the heels of its <a href=\"https://seekingalpha.com/pr/16738813-tracon-pharmaceuticals-announces-top-line-results-nci-sponsored-phase-2-trial-trc105\" target=\"_blank\">announcement </a>of results from a Phase 2 clinical trial assessing lead product candidate TRC105 in recurrent glioblastoma &#40;GBM&#41;.</li><li>The study evaluated the effect on three-month progression-free survival &#40;PFS&#41; of TRC105 combined with Roche's Avastin (bevacizumab) compared to the expected value of 3.45 months for Avastin alone. Top-line results showed that the addition of TRC105 failed to significantly improve PFS, although there was a numerical increase in overall survival.</li><li>Detailed results will be presented at an oncology conference &#40;ASCO&#41; later this year.</li><li><a href=\"http://www.traconpharma.com/clinical_trials.php\" target=\"_blank\">TRC105</a>&nbsp;(carotuximab) is a novel clinical-stage antibody to endoglin, a protein overexpressed on proliferating endothelial cells that is essential for angiogenesis. It has Orphan Drug status for the treatment of soft tissue sarcoma and Fast Track status for kidney cancer.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>20%</font>&nbsp;premarket on increased volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3242448\" data-linked=\"TRACON Pharma&#39;s lead product candidate flunks mid-stage study in brain cancer\" data-tweet=\"$TCON - TRACON Pharma&#39;s lead product candidate flunks mid-stage study in brain cancer https://seekingalpha.com/news/3242448-tracon-pharmas-lead-product-candidate-flunks-mid-stage-study-in-brain-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3242448-tracon-pharmas-lead-product-candidate-flunks-mid-stage-study-in-brain-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:49 AM </div></div></li>","count":55,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}